BridgeMD
Compares treatment options for Inguinal Hernia
Official title Modified Guarnieri-Desarda Technique Versus Lichtenstein Technique in Inguinal Hernia Repair
ClinicalTrials.gov ID: NCT06595628
What this study is testing
- What it's testing
- The aim of this study is to compare the surgical outcome of both Lichnichtien tension free mesh hernioplasty of inguinal hernia and the combined modified Guarnieri Desarda technique in terms of postoperative pain, post operative complications (seroma, hematoma, wound infection), chronic inguinodenia, early recurrence and assessment of testicular vascularity and size by application of a testicular duplex and ultrasound.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Adult male patients aged 18 years or older.
- Patients diagnosed with non-complicated inguinal hernia (both direct and indirect).
- Patients able to provide written informed consent to participate in the study.
You likely can't join if
- Patients younger than 18 years old.
- Patients with complicated hernias (e.g., inflamed, obstructed, or strangulated hernias).
- Patients with a recurrent inguinal hernia.
- Patients with weak or thin external oblique aponeurosis (intraoperative findings).
- Patients with a history of prior surgery in the inguinal region.
- Patients who refuse to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.